Roth Capital Starts PTC Therapeutics (PTCT) at Buy
Tweet
Share
E-mailGet Alerts PTCT Hot Sheet
Price: $84.85 -5.25%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 17
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 17
Join SI Premium – FREE
Roth Capital initiated coverage on PTC Therapeutics (NASDAQ: PTCT) with a Buy rating and a price target of $34.00.
For an analyst ratings summary and ratings history on PTC Therapeutics click here. For more ratings news on PTC Therapeutics click here.
Shares of PTC Therapeutics closed at $27.26 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Equirus Starts JSW Energy Ltd (JSW:IN) at Long (1)
- HSBC Starts Parkway Life REIT (PREIT:SP) (PRKWF) at Buy
- Macquarie Starts Haier Smart Home Co., Ltd (6690:HK) (HRSHF) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
